Trial · NCT01847014
Adverse events23
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 23
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Hyperlipidaemia | Metabolism and nutrition disorders | Macitentan | 1 | 4 | 1 |
| other | Hypokalaemia | Metabolism and nutrition disorders | Macitentan | 1 | 4 | 1 |
| other | Type 2 Diabetes Mellitus | Metabolism and nutrition disorders | Macitentan | 1 | 4 | 1 |
| other | Hypoglycaemia | Metabolism and nutrition disorders | Macitentan | 1 | 4 | 1 |
| other | Right Heart Failure | Cardiac disorders | Macitentan | 1 | 4 | 1 |
| other | Vertigo | Ear and labyrinth disorders | Macitentan | 1 | 4 | 1 |
| other | Diarrhoea | Gastrointestinal disorders | Macitentan | 1 | 4 | 1 |
| other | Nausea | Gastrointestinal disorders | Macitentan | 1 | 4 | 1 |
| other | Vomiting | Gastrointestinal disorders | Macitentan | 1 | 4 | 1 |
| other | Chest Pain | General disorders | Macitentan | 1 | 4 | 1 |
| other | Pain In Jaw | Musculoskeletal and connective tissue disorders | Macitentan | 1 | 4 | 1 |
| other | Headache | Nervous system disorders | Macitentan | 1 | 4 | 1 |
| other | Renal Impairment | Renal and urinary disorders | Macitentan | 1 | 4 | 1 |
| other | Chronic Obstructive Pulmonary Disease Exacerbation | Respiratory, thoracic and mediastinal disorders | Macitentan | 1 | 4 | 1 |
| other | Pulmonary Arterial Hypertension Exacerbation | Respiratory, thoracic and mediastinal disorders | Macitentan | 1 | 4 | 1 |
| other | Pulmonary Hypertension Exacerbation | Respiratory, thoracic and mediastinal disorders | Macitentan | 1 | 4 | 1 |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | Macitentan | 1 | 4 | 1 |
| other | Hyperhidrosis | Skin and subcutaneous tissue disorders | Macitentan | 1 | 4 | 1 |
| other | Flushing | Vascular disorders | Macitentan | 1 | 4 | 1 |
| serious | Chronic Obstructive Pulmonary Disease Exacerbation | Respiratory, thoracic and mediastinal disorders | Macitentan | 1 | 4 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01847014/events